|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | |||||
| Net loss from continuing operations | |||||
| Adjustments to reconcile net loss to net cash provided by operating activities | |||||
| Non-cash adjustments on derivatives and non-cash interest expense (income) | |||||
| Amortization of deferred financing fees | |||||
| Impairment of goodwill and indefinite-lived asset | |||||
| Extinguishment costs related to repayment and repricing of long-term debt | |||||
| Depreciation and amortization | |||||
| Change in fair value of warrant liability | |||||
| Fair value adjustments related to contingent consideration | |||||
| Deferred income taxes | |||||
| Equity-based compensation of Karman Topco L.P. | |||||
| Stock-based compensation | |||||
| Equity in earnings of unconsolidated affiliates | |||||
| Income from investment in European joint venture and other | |||||
| Distribution received from equity method investments | |||||
| Gain on deconsolidation of subsidiaries | |||||
| Gain on divestiture and deconsolidation of subsidiaries | |||||
| Gain on repurchases of Senior Secured Notes and Term Loan Facility debt | |||||
| Loss on disposal of property and equipment | |||||
| Loss on divestitures | |||||
| Loss on divestiture | |||||
| Other | |||||
| Deferred financing fees related to repricing of long-term debt | |||||
| Changes in operating assets and liabilities, net of effects from divestitures: | |||||
| Accounts receivable, net | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Accrued compensation and benefits | |||||
| Deferred revenues | |||||
| Other accrued expenses and other liabilities | |||||
| Net cash provided by operating activities | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES | |||||
| Purchase of businesses, net of cash acquired | |||||
| Purchase of investments in unconsolidated affiliates | |||||
| Purchase of property and equipment | |||||
| Purchase and development of capitalized software | |||||
| Proceeds from divestitures | |||||
| Deconsolidation of subsidiaries cash and cash equivalents and restricted cash, net of proceeds | |||||
| Proceeds from sale of investments in unconsolidated affiliates | |||||
| Net cash (used in) provided by investing activities | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES | |||||
| Borrowings under lines of credit | |||||
| Payments on lines of credit | |||||
| Proceeds from government loans for COVID-19 relief | |||||
| Principal payments on long-term debt | |||||
| Repurchases of Senior Secured Notes and Term Loan Facility debt | |||||
| Debt issuance costs | |||||
| Deferred consideration paid for purchases in unconsolidated affiliates | |||||
| Contingent consideration payments | |||||
| Proceeds from employee stock purchase plan | |||||
| Payments for taxes related to net share settlement of equity awards | |||||
| Holdback payments | |||||
| Financing fees paid | |||||
| Contribution from noncontrolling interest | |||||
| Redemption of noncontrolling interest | |||||
| Purchase of treasury stock | |||||
| Net cash used in financing activities | |||||
| Net effect of foreign currency changes on cash, cash equivalents and restricted cash | |||||
| Net change in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash, beginning of period | |||||
| Cash, cash equivalents and restricted cash, end of period | |||||
| Exchange of ownership of SPV for fair value of GSH | |||||
| Non-cash proceeds from divestitures | |||||
| Purchase of property and equipment recorded in accounts payable and accrued expenses | |||||
| Cash payments for interest | |||||
| Cash received from interest rate derivatives | |||||
| Cash payments for income taxes, net | |||||
Loading...